Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1443 of 6351
-
Could a cheap vitamin pill boost brain healing after head injury?
Disease control Recruiting nowThis study is a Phase II, randomized, quadruple-blinded, placebo-controlled clinical trial designed to test whether vitamin D₃ supplementation can improve recovery after mild-to-moderate traumatic brain injury (TBI) in adults. Traumatic brain injury often leads to inflammation a…
Phase 2 • Sponsor: Lagos State University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Weekly shot could slow kidney damage in CKD patients
Disease control Not yet recruitingThe ARTIST-CKD trial is a clinical study evaluating the effect of weekly subcutaneous administration of survodutide (3.6 mg) on kidney function in patients with chronic kidney disease (CKD) and elevated albuminuria. The primary objective is to determine whether survodutide leads …
Phase 2 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could donor milk save tiny babies from deadly gut disease?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate whether supplementing with pasteurized donor human milk (pHDM) or preterm formula (PTF) when own mother's milk (OMM) is insufficient can improve outcomes in very preterm infants born before 29 weeks of gestation. It also aims to asse…
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could two steroids slash septic shock deaths?
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of the combination therapy of hydrocortisone and fludrocortisone among adult patients with septic shock.
Phase 4 • Sponsor: Northern Jiangsu People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New study aims to tackle PTSD and obesity in veterans with one program
Disease control Recruiting nowObesity and post-traumatic stress disorder (PTSD) are common among Veterans. PTSD increases risk for obesity, impacting functioning, health, quality of life, and premature mortality. Use of proven treatments for PTSD and obesity in VA is low. Furthermore, Veterans with PTSD lose …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Glow-in-the-Dark dye could help surgeons spot brain tumors
Diagnosis Not yet recruitingParticipants in this research study are people who are likely to have, or have been diagnosed with a brain tumor, for which surgical removal (or "resection") is the standard of care treatment. The purpose of this study is to see whether a drug called SBK2-ICG can be used to locat…
Phase 1 • Sponsor: Tiffany Hodges • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
New stent graft for aortic arch disease tracked for 10 years
Disease control Recruiting nowA prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Could a tiny zap ease endometriosis agony? new trial aims to find out.
Symptom relief Not yet recruitingEndometriosis is a condition that often causes pelvic pain, particularly during menstruation but also continuously and over long periods. Pharmacological treatments are only moderately effective or are associated with adverse effects. In this context, the search for non-pharmacol…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New nanoparticle drug aims to fight tough lung cancer
Disease control Recruiting nowThe purpose of the Phase 1 research is to test the safety, tolerability, maximum tolerated dose, and pharmacokinetics (PK- the study of how a medicine moves through subject body. It looks at how the drug is absorbed, travels in your blood, reaches different parts of subject body,…
Phase 1/2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New radiation applicator aims to treat rectal cancer without surgery
Disease control Not yet recruitingRectal cancer is a common type of cancer and an important cause of illness and death worldwide. In 2020, cancers of the colon and rectum were the fourth most common cancers globally, and about one third of these cases were rectal cancer. Surgery is the main treatment for rectal c…
Phase 2 • Sponsor: Siriraj Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a simple protein infusion prevent deadly Re-Bleeding in cirrhosis patients?
Disease control Not yet recruitingThe objective of this randomized control clinical trial is to learn the role of albumin in patients with acute variceal bleed. The trial will include all adult patients with acute variceal bleeding and cirrhosis presenting to Medical Gastroenterology department at KGMU, Lucknow, …
Phase 3 • Sponsor: King George's Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Rotational exercises may cut fall risk in Parkinson's patients
Symptom relief Recruiting nowThis study aims to contribute to clinical applications by investigating the effectiveness of functional rotation exercises on fall risk, mobility, and balance in patients diagnosed with idiopathic Parkinson's disease.
Sponsor: Uskudar University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pill could tame rare blood disorder when other treatments fail
Disease control Recruiting now1. wAIHA Treatment Regimen: Group A (50mg group): Orelabrutinib 50 mg, orally, once daily. After 4 weeks of treatment, if still transfusion-dependent or hemoglobin increase is \< 20 g/L, the dose may be increased to 100 mg qd. Treatment can be discontinued if ineffective at 12 we…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a skin patch before surgery ease Post-Op pain?
Symptom relief Recruiting nowPostoperative pain remains a major challenge after video-assisted thoracoscopic surgery (VATS), despite the use of multimodal analgesia. This randomized, triple-blind, placebo-controlled clinical trial will evaluate whether adding a 5 mcg/hour transdermal buprenorphine patch to t…
Sponsor: Clínica Dávila • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New vaccine aims to control or cure chronic hepatitis b
Disease control Not yet recruitingThis is a pilot study to determine the safety and efficacy of a novel adjuvanted hepatitis B virus (HBV) vaccine formulated as a potential therapeutic vaccine against chronic HBV infection. An ongoing human clinical trial of this HBV vaccine in a prophylactic setting has confirme…
Phase 1/2 • Sponsor: Vaxine Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New group program aims to save LGBTQ+ veterans from suicide
Knowledge-focused Recruiting nowDespite the high risk of suicide among LGBTQ+ Veterans, there is currently no suicide-focused intervention for this population. This study will refine and pilot Qnnections, a novel group-based suicide prevention intervention that aims to increase social connection and functioning…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Could epilepsy and blood disorder drugs take on brain cancer?
Disease control Recruiting nowGlioblastoma is the most common and aggressive form of brain cancer in adults. Despite surgery, radiotherapy, and chemotherapy, most patients only live about one year after diagnosis. There is an urgent need for new and better treatments. Recent research has shown that glioblast…
Early phase 1 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could coiling an artery in the head stop migraines?
Disease control Not yet recruitingThis single-site, open-label pilot study evaluates the safety, feasibility, and potential durability of the TEMMA procedure (Targeted Embolization for Migraine Management), an endovascular treatment strategy targeting meningeal arterial contributors to migraine. Adults aged 18-60…
Sponsor: Cortex Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New study: could a daily supplement and strength training beat menopause blues?
Symptom relief Recruiting nowThe aim of this clinical trial is to determine if resistance training and a newly developed plant-based nutritional supplement can improve the symptoms and musculoskeletal health of perimenopausal women. The main questions it aims to evaluate are: 1. Can resistance training and…
Sponsor: Leeds Beckett University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Could a pill tame aggression in fragile x? new trial aims to find out
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if drug SRX246 works to treat irritability, agitation, aggression and self-injury (IAAS) behaviors in adult males with Fragile X Syndrome (FXS). It will also learn about the safety of drug SRX246. The main questions it aims to answer ar…
Phase 2 • Sponsor: Azevan Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC